ConductScience.org, home

Paper40901928

HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells.

Lewis CA and 2 others. PLoS Pathog, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells. Papers, record 40901928. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40901928

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells.
PubMed
Journal
PLoS Pathog
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lewis CACatherine Ahttps://orcid.org/0000-0001-7848-869X
2Margolis DMDavid M
3Browne EPEdward Phttps://orcid.org/0000-0001-9070-7015

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD4-Positive T-LymphocytesMajor topic
HIV-1Major topic
vpr Gene Products, Human Immunodeficiency VirusMajor topic
Virus LatencyMajor topic
HIV InfectionsMajor topic
Histone DeacetylasesMajor topic
E1A-Associated p300 ProteinMajor topic
Humans
Histone Deacetylase Inhibitors
Transcription, Genetic
Vorinostat
Hydroxamic Acids

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 AI050410NIAID NIH HHSUnited StatesP30AI050410PubMed and NIHNIH RePORTER
R01 AI143381NIAID NIH HHSUnited StatesR01AI143381PubMed and NIHNIH RePORTER
UM1 AI164567NIAID NIH HHSUnited StatesUM1AI164567PubMed and NIHNIH RePORTER

Download CSV of grants

References86

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117620334The HIV1 protein Vpr acts to promote G2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor.J Biol Chem2007https://conductscience.org/library/papers/17620334PubMed
231042482Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.Cell Rep2019https://conductscience.org/library/papers/31042482PubMed
37815499Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.J Virol1995https://conductscience.org/library/papers/7815499PubMed
427550312HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.Sci Rep2016https://conductscience.org/library/papers/27550312PubMed
58642659Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.J Virol1996https://conductscience.org/library/papers/8642659PubMed
633332394Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.PLoS One2020https://conductscience.org/library/papers/33332394PubMed
731597754The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation.Sci Transl Med2019https://conductscience.org/library/papers/31597754PubMed
823846220Altering cell death pathways as an approach to cure HIV infection.Cell Death Dis2013https://conductscience.org/library/papers/23846220PubMed
924336828A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.Clin Infect Dis2014https://conductscience.org/library/papers/24336828PubMed
109360926Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.Science1997https://conductscience.org/library/papers/9360926PubMed
119371822Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9371822PubMed
1229100385Histone deacetylase inhibitors vorinostat and panobinostat induce G1 cell cycle arrest and apoptosis in multidrug resistant sarcoma cell lines.Oncotarget2017https://conductscience.org/library/papers/29100385PubMed
1325253353Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.J Virol2014https://conductscience.org/library/papers/25253353PubMed
1431217357Clones of infected cells arise early in HIV-infected individuals.JCI Insight2019https://conductscience.org/library/papers/31217357PubMed
1521566118Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.J Biol Chem2011https://conductscience.org/library/papers/21566118PubMed
169427608HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.Nat Med1998https://conductscience.org/library/papers/9427608PubMed
1738134881A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells.Cell Chem Biol2023https://conductscience.org/library/papers/38134881PubMed
1831396206Illuminating the Role of Vpr in HIV Infection of Myeloid Cells.Front Immunol2019https://conductscience.org/library/papers/31396206PubMed
1915832178To kill or be killed: how HIV exhausts the immune system.Cell Death Differ2005https://conductscience.org/library/papers/15832178PubMed
202136707Identification of HIV-1 vpr product and function.J Acquir Immune Defic Syndr (1988)1990https://conductscience.org/library/papers/2136707PubMed

See all 86 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42836275Manipulation of the cell cycle by HIV-1.Biochem Soc Trans2026https://conductscience.org/library/papers/42836275

Source PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
HDAC99734PubTator's text mininghttps://conductscience.org/library/genes/9734NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40901928

GET https://conductscience.org/api/papers/v1/40901928/references?page=2